DSS

DSS, Inc.

$0.45

-8.71%
SectorConsumer CyclicalIndustryPackaging & ContainersCountryUnited States

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza.

Source: Yahoo Finance
AI summary

Price & performance

1M-24.7%
3M-12.0%
YTD-44.5%
1Y-60.8%
52-week range—
Beta0.09
Full chart and returns against a benchmark

Q-Score

16/ 100

Quality against peers; 50 is the peer median.

Growth21
Risk33
Performance31
Valuation—
Profitability22
Leverage20
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$20.8M+8.7%
Net income-$23.9M
Net margin-115.3%+130.3 pts
Historical fundamentals

Red flags in filings

3active red flags
Going-concern doubtMar 31, 2026
Material weakness in controlsMar 31, 2026
Auditor changeJul 1, 2025
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer29%
Regions, segments, customers and suppliers

Valuation

DSSIndustryP/E—117.45P/S—0.98EV/EBITDA—13.12P/B—2.16PEG——
Dividend yield—
Every valuation metric